Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Debbie S. Deben, Dennis R. Wong & Adriaan A. van Bodegraven. (2021) Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1433-1444.
Read now
Read now
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters & Nanne K. De Boer. (2020) The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review. Expert Opinion on Drug Metabolism & Toxicology 16:2, pages 111-123.
Read now
Read now
Dirk P. van Asseldonk, Melek Simsek, Nanne K. H. de Boer, Bindia Jharap, Elisabeth Bloemena, Gijsbert den Hartog, Dik B. Westerveld, Marco C. Becx, Maurice G. Russel, Birgit I. Lissenberg-Witte, Carin M. van Nieuwkerk, Chris J. J. Mulder, Joanne Verheij & Adriaan A. van Bodegraven. (2019) Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients. Scandinavian Journal of Gastroenterology 54:6, pages 753-760.
Read now
Read now
Kirstin M. Taylor, Mark G. Ward, Paul A. Blaker & Miles P. Sparrow. (2017) Is there a role for thioguanine therapy in IBD in 2017 and beyond?. Expert Review of Gastroenterology & Hepatology 11:5, pages 473-486.
Read now
Read now
Rimma Goldberg & Peter M Irving. (2015) Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 9:7, pages 891-900.
Read now
Read now
Leon P McLean & Raymond K Cross. (2014) Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Review of Gastroenterology & Hepatology 8:3, pages 223-240.
Read now
Read now
Wojciech Błogowski, Wojciech Marlicz, Andrzej Smereczyński, Małgorzata Ławniczak, Agnieszka Lewosiuk & Teresa Starzyńska. (2011) Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn’s disease. Immunopharmacology and Immunotoxicology 33:2, pages 398-402.
Read now
Read now
Christina Ha & Themistocles Dassopoulos. (2010) Thiopurine therapy in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 4:5, pages 575-588.
Read now
Read now
Articles from other publishers (56)
Madhumita Premkumar & Anil C. Anand. (2024) Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance. Journal of Clinical and Experimental Hepatology 14:5, pages 101396.
Crossref
Crossref
Fares E.M. Ali, Mustafa Ahmed Abdel-Reheim, Emad H.M. Hassanein, Mostafa K. Abd El-Aziz, Hanan S. Althagafy & Khalid S.A. Badran. (2024) Exploring the potential of drug repurposing for liver diseases: A comprehensive study. Life Sciences 347, pages 122642.
Crossref
Crossref
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia & Massoud Vosough. (2024) Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 18:3, pages 360-374.
Crossref
Crossref
Ahmed B. Bayoumy, Chris J. J. Mulder, Azhar R. Ansari, Murray L. Barclay, Tim Florin, Marianne Kiszka-Kanowitz, Luc Derijks, Vishal Sharma & Nanne K. H. de Boer. (2024) Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care. Indian Journal of Gastroenterology 43:1, pages 36-47.
Crossref
Crossref
Christopher O.C. Bellamy & Alastair D. Burt. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
1039
1095
.
Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi & Alessio Aghemo. (2023) Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review. Digestive and Liver Disease.
Crossref
Crossref
Nicola Pugliese, Arianna Dal Buono & Alessandro Armuzzi. (2023) Unveiling the Complexity of Porto-Sinusoidal Vascular Disorder in Inflammatory Bowel Disease: A Call for Further Investigation. Journal of Crohn's and Colitis 17:11, pages 1892-1892.
Crossref
Crossref
Femke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, Job H C Peters, Paul J Boekema, Luc J J Derijks, Sybrand Y de Boer, Paul C van de Meeberg, Ishfaq Ahmad, Hans J C Buiter & Nanne K de Boer. (2023) The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases.
Crossref
Crossref
Pooja Abbey & Shalimar. (2023) Nodular Regenerative Hyperplasia. Current Hepatology Reports 22:3, pages 182-192.
Crossref
Crossref
Marta MagazHeloïse Giudicelli-LettOana Nicoară-FarcăuNeil RajoriyaAshish GoelKarlien RaymenantsSophie HillaireGonzalo CrespoLuis TéllezLaure ElkriefConstantino FondevilaLara OrtsFilipe NeryAkash ShuklaHélène LarrueYiliam FundoraHelena DegrooteVictoria AguileraElba LLopLaura TurcoFederica IndultiStefania GioiaGiulia TosettiNiccolò BittoChiara BecchettiEdilmar AlvaradoCristina RoigRaquel DiazMichael PraktiknjoAnna-Lena KonicekGuillem SoyPol OlivasJosé Ignacio ForteaHelena MasnouÁngela PuenteAlba ArdèvolCarmen Álvarez-NavascuésMarta RomeroBernhard ScheinerGeorg SemmlerMattias MandorferFilipe DamiãoAnna BaigesFanny TuronMacarena Simón-TaleroCarlos González-AlayónAlba DíazÁngeles García-CriadoAndrea de GottardiEnric ReverterAnnabel BlasiJoan GenescàOlivier RouxClaire FrancozCarlos Noronha FerreiraThomas ReibergerManuel RodríguezRosa María MorillasJavier CrespoJonel TrebickaRafael BañaresCàndid VillanuevaAnnalisa BerzigottiMassimo PrimignaniVincenzo La MuraOliviero RiggioFilippo SchepisBogdan ProcopetXavier VerhelstJosé Luis CallejaChristophe BureauAgustín AlbillosFrederik NevensVirginia Hernández-GeaDhiraj TripathiPierre-Emmanuel RautouFrançois DurandJuan Carlos García-Pagán. (2023) Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome. Transplantation 107:6, pages 1330-1340.
Crossref
Crossref
Adil S. MIR & Dario SORRENTINO. (2023) Non-cirrhotic portal hypertension in inflammatory bowel disease. Minerva Gastroenterology 69:2.
Crossref
Crossref
Ahmed B. Bayoumy, Jasmijn Z. Jagt, Herbert M. van Wering, Lissy de Ridder, Thalia Hummel, Victorien M. Wolters, Janneke Stapelbroek, Marc A. Benninga, Chris J.J. MulderNanne K.H. de BoerTim G.J. de Meij. (2022) Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series. Journal of Pediatric Gastroenterology & Nutrition 75:6, pages e111-e115.
Crossref
Crossref
Ashkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, Liekele Oostenbrug, Mariëlle Romberg‐Camps, Daisy Jonkers, Adriaan van Bodegraven & Marieke Pierik. (2022) Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 56:6, pages 1030-1043.
Crossref
Crossref
Nazli Begum Ozturk, Maria Isabel Fiel & Thomas D. Schiano. (2022) Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis. JGH Open 6:9, pages 607-611.
Crossref
Crossref
Femke Crouwel, Hans J C Buiter & Nanne K de Boer. (2022) The Thiopurine Tale: An Unexpected Journey. Journal of Crohn's and Colitis 16:7, pages 1177-1183.
Crossref
Crossref
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh & Rohit Loomba. (2022) Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 55:8, pages 894-907.
Crossref
Crossref
Laure Elkrief & Laura Rubbia-Brandt. 2022. Vascular Disorders of the Liver. Vascular Disorders of the Liver
345
363
.
Lennard P.L. Gilissen, Rudaba Tajzai, Marielle Romberg, Marieke Pierik, Arnold Stronkhorst, Karin Steenhuisen, Ad Van Bodegraven, Alette Daniels & Dennis Wong. (2020) The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology 33:1S, pages e102-e107.
Crossref
Crossref
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder & Azhar Ansari. (2020) Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterology 20:1.
Crossref
Crossref
Vince B. C. Biemans, Edo Savelkoul, Ruben Y. Gabriëls, Melek Simsek, Gerard Dijkstra, Marieke J. Pierik, Rachel L. West, Nanne K.H. de Boer & Frank Hoentjen. (2020) A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics 51:11, pages 1076-1086.
Crossref
Crossref
Zi-Yuan Zou, Bo Shen & Jian-Gao Fan. (2019) Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 25:11, pages 1764-1772.
Crossref
Crossref
Linea Natalie Toksvang, Magnus Strøh Schmidt, Sofie Arup, Rikke Hebo Larsen, Thomas Leth Frandsen, Kjeld Schmiegelow & Cecilie Utke Rank. (2019) Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review. PLOS ONE 14:5, pages e0212157.
Crossref
Crossref
Melek Simsek, Berrie Meijer, Dewkoemar Ramsoekh, Gerd Bouma, Egbert-Jan van der Wouden, Bert den Hartog, Annemarie C. de Vries, Frank Hoentjen, Gerard Dijkstra, Sybrand Y. de Boer, Jeroen M. Jansen, Andrea E. van der Meulen, Ruud Beukers, Menno A. Brink, Toos Steinhauser, Bas Oldenburg, Lennard P. Gilissen, Ton H. Naber, Marc A. Verhagen, Nanne K.H. de Boer & Chris J.J. Mulder. (2019) Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients. Clinical Gastroenterology and Hepatology 17:3, pages 568-570.
Crossref
Crossref
Lucy Shamberg & Haleh Vaziri. (2018) Hepatotoxicity of Inflammatory Bowel Disease Medications. Journal of Clinical Gastroenterology 52:8, pages 674-684.
Crossref
Crossref
Berrie Meijer, Chris J J Mulder, Gerd Bouma, Cyriel Y Ponsioen, C Janneke van der Woude, Andrea E van der Meulen, Dion S J Wintjens, Gerard Dijkstra, Frank Hoentjen, Bas Oldenburg, Adriaan A van Bodegraven & Nanne K H de Boer. (2018) Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness. Inflammatory Bowel Diseases 24:7, pages 1558-1565.
Crossref
Crossref
Nanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, Jeremy D Sanderson, Berrie Meijer, Imke Atreya, Murray L Barclay, Jean-Frederic Colombel, Anthony Lopez, Laurent Beaugerie, Anthony M Marinaki, Adriaan A van Bodegraven & Markus F Neurath. (2018) Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives. Journal of Crohn's and Colitis 12:5, pages 610-620.
Crossref
Crossref
Clémence Legué, Ludivine Legros, Solène Kammerer-Jacquet, Caroline Jézequel, Pauline Houssel-Debry, Thomas Uguen, Caroline Le Lan, Anne Guillygomarc’h, Romain Moirand, Bruno Turlin, Dominique Guyader & Edouard Bardou-Jacquet. (2018) Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 16:2, pages 290-291.
Crossref
Crossref
Chris Bellamy & Alastair D. Burt. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
966
1018
.
Raj Vuppalanchi & Naga Chalasani. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach
43
53
.
A. Le Joncour & D. Saadoun. (2017) Manifestaciones hepáticas de las enfermedades sistémicas y las hemopatías. EMC - Tratado de Medicina 21:3, pages 1-11.
Crossref
Crossref
Berrie Meijer, Melek Simsek, Hans Blokzijl, Robert A Man, Minneke J Coenraad, Gerard Dijkstra, Carin MJ Nieuwkerk, Chris JJ Mulder & Nanne KH Boer. (2017) Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20‐year cohort study in all Dutch liver transplant units. United European Gastroenterology Journal 5:5, pages 658-667.
Crossref
Crossref
Mark G Ward, Kamal V Patel, Viraj C Kariyawasam, Rishi Goel, Ben Warner, Tim R Elliott, Paul A Blaker, Peter M Irving, Anthony M Marinaki & Jeremy D Sanderson. (2017) Thioguanine in inflammatory bowel disease: Long‐term efficacy and safety. United European Gastroenterology Journal 5:4, pages 563-570.
Crossref
Crossref
Margien L. Seinen, Dirk P. van Asseldonk, Nanne K. de Boer, Gerd Bouma, Carin M. van Nieuwkerk, Chris J. Mulder, Elisabeth Bloemena & Adriaan A. van Bodegraven. (2017) Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol–Thiopurine Combination Therapy. Inflammatory Bowel Diseases 23:3, pages 448-452.
Crossref
Crossref
My-Linh Tran-Minh, Paula Sousa, Marianne Maillet, Matthieu Allez & Jean-Marc Gornet. (2017) Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World Journal of Hepatology 9:13, pages 613.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
2091
2116
.
Thomas J. Byrne & Alvin C. Silva. 2016. Practical Gastroenterology and Hepatology Board Review Toolkit. Practical Gastroenterology and Hepatology Board Review Toolkit
442
449
.
Dirk P. van Asseldonk, Bindia Jharap, Joanne Verheij, Gijsbert den Hartog, Dik B. Westerveld, Marco C. Becx, Maurice G. Russel, Leopold G. Engels, Dirk J. de Jong, Birgit I. Witte, Chris J. Mulder, Carin M. van Nieuwkerk, Elisabeth Bloemena, Nanne K. H. de Boer & Ad A. van Bodegraven. (2016) The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease. Inflammatory Bowel Diseases 22:9, pages 2112-2120.
Crossref
Crossref
Mehmet Coskun, Casper Steenholdt, Nanne K. de Boer & Ole Haagen Nielsen. (2015) Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease. Clinical Pharmacokinetics 55:3, pages 257-274.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
26
.
Jeoffrey NL Schouten, Joanne Verheij & Susana Seijo. (2015) Idiopathic non-cirrhotic portal hypertension: a review. Orphanet Journal of Rare Diseases 10:1.
Crossref
Crossref
Chiara Marzano, Dominique Cazals‐Hatem, Pierre‐Emmanuel Rautou & Dominique‐Charles Valla. (2015) The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome. Hepatology 62:3, pages 956-963.
Crossref
Crossref
Bindia Jharap, Dirk P. van Asseldonk, Nanne K. H. de Boer, Pierre Bedossa, Joachim Diebold, A. Mieke Jonker, Emmanuelle Leteurtre, Joanne Verheij, Dominique Wendum, Fritz Wrba, Pieter E. Zondervan, Jean-Frédéric Colombel, Walter Reinisch, Chris J. J. Mulder, Elisabeth Bloemena & Adriaan A. van Bodegraven. (2015) Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement. PLOS ONE 10:6, pages e0120299.
Crossref
Crossref
Torsten Schröder, Klaus J. Schmidt, Vera Olsen, Steffen Möller, Tilo Mackenroth, Christian Sina, Hendrik Lehnert, Klaus Fellermann & Jürgen Büning. (2015) Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. European Journal of Gastroenterology & Hepatology 27:6, pages 698-704.
Crossref
Crossref
C. O. Musumba. (2013) Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy. Alimentary Pharmacology & Therapeutics 38:9, pages 1025-1037.
Crossref
Crossref
Alberto Quaglia, Alastair D. Burt, Linda D. Ferrell & Bernard C. Portmann. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
935
986
.
Miloslav Kverka, Pavel Rossmann, Helena Tlaskalova-Hogenova, Klara Klimesova, Bindia Jharap, Nanne K de Boer, Rene M Vos, Adriaan A van Bodegraven, Milan Lukas & Chris J Mulder. (2011) Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. BMC Gastroenterology 11:1.
Crossref
Crossref
Jeoffrey N.L. Schouten, Juan C. Garcia-Pagan, Dominique C. Valla & Harry L.A. Janssen. (2011) Idiopathic noncirrhotic portal hypertension. Hepatology 54:3, pages 1071-1081.
Crossref
Crossref
Dirk P. van Asseldonk, Jeremy Sanderson, Nanne K.H. de Boer, Miles P. Sparrow, Marc Lémann, Azhar Ansari, Sven H. Almer, Timothy H.J. Florin, Richard B. Gearry, Chris J. Mulder, Gerassimos Mantzaris & Ad A. van Bodegraven. (2011) Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting. Digestive and Liver Disease 43:4, pages 270-276.
Crossref
Crossref
Dirk P. van Asseldonk, Bindia Jharap, Dirk J. Kuik, Nanne K.H. de Boer, Barend D. Westerveld, Maurice G.V.M. Russel, Frank J.G.M. Kubben, Ad A. van Bodegraven & Chris J. Mulder. (2011) Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis. Digestive and Liver Disease 43:2, pages 110-115.
Crossref
Crossref
Emma Calabrese & Stephen B. Hanauer. (2011) Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease. Journal of Crohn's and Colitis 5:1, pages 48-53.
Crossref
Crossref
Philippe Seksik, Jean-Yves Mary, Laurent Beaugerie, Marc Lémann, Jean-Frederic Colombel, Gwenolla Vernier-Massouille & Jacques Cosnes. (2011) Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine. Inflammatory Bowel Diseases 17:2, pages 565-572.
Crossref
Crossref
G. Geri, D. Saadoun & P. Cacoub. (2011) Manifestaciones hepáticas de las enfermedades sistémicas y de las hemopatías. EMC - Tratado de Medicina 15:2, pages 1-9.
Crossref
Crossref
G. Geri, D. Saadoun & P. Cacoub. (2011) Manifestations hépatiques des maladies systémiques et des hémopathies. EMC - Traité de médecine AKOS 6:1, pages 1-9.
Crossref
Crossref
Thomas J. Byrne. 2010. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Practical Gastroenterology and Hepatology: Liver and Biliary Disease
95
104
.
Jude M. Morris, Karin A. Oien, Marie McMahon, Ewan H. Forrest, John Morris, Adrian J. Stanley & Stewart Campbell. (2010) Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. European Journal of Gastroenterology & Hepatology 22:8, pages 1001-1005.
Crossref
Crossref
Anthony O'ConnorAsghar Qasim & Colm A. O'Moráin. (2010) The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease. Therapeutic Advances in Chronic Disease 1:1, pages 7-16.
Crossref
Crossref